24СʱÈÈÃŰæ¿éÅÅÐаñ    

Znn3bq.jpeg
²é¿´: 1754  |  »Ø¸´: 8
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

³ÕÃÎäìÏæ

ľ³æ (ÖøÃûдÊÖ)


[½»Á÷] ºóÁ¢ÆÕÍ×ʱ´ú£º½µÖ¬Ò©ÎïµÄÏÂÒ»Ôö³¤µãÔÚÄÄÀ ÒÑÓÐ8È˲ÎÓë

¸ù¾ÝFiercePharmaµÄÊý¾Ý£¨www.fiercepharma.com/special-reports/top-10-cardio-drugs-2012£©£¬ÓÉÓÚÊÜרÀûÐüѵÄÓ°Ï죬2012ÄêÐÄѪ¹ÜÒ©ÎïTop10µÄ×ÜÏúÊÛ¶î´Ó2011ÄêµÄ372.71ÒÚÃÀÔª½µÎª286.44ÒÚÃÀÔª¡£ÌرðÊÇ»ÔÈðµÄLiptor£¬2011ÄêÏúÊÛ¶îΪ95.77ÒÚÃÀÔª£¬µ«2012Äê½öÓÐ39.48ÒÚÃÀÔª£¬¶øÄ¿Ç°×ÏúµÄCrestorÒ²½«ÔÚ2016ÄêרÀûµ½ÆÚ£¬Î´À´¼¸ÄêÏ»¬Ç÷ÊÆËÆºõ²»¿ÉÄæ×ª¡£

¶øDecision Resources×îз¢²¼µÄ±¨¸æÏÔʾ£¬2012-2022Äê¼ä½µÑªÖ¬Ò©ÎïÊг¡ÈÔ½«ÒÔ2%µÄËÙ¶ÈÔö³¤£¬ÖÁ2022Äê´ïµ½310ÒÚÃÀÔª¡£ÐµÄÔö³¤µãÀ´×ÔÁ½ÀàÐÂÒ©£ºCETPÒÖÖÆ¼ÁÓëanti-PCSK9µ¥¿¹£¬¸öÈ˱ȽϿ´ºÃanti-PCSK9µ¥¿¹£¬µ«¶ÔCETPÒÖÖÆ¼ÁûʲôºÃ¸Ð¡£

CETPÈ«³Æµ¨¹Ì´¼õ¥×ªÒƵ°°×£¨cholesterylester transfer protein£©£¬ËüÄÜ´ÙʹVLDL¡¢LDL½«¸ÊÓÍÈýõ¥×ªÒƸøHDL£¬¶ø½«HDLµÄµ¨¹Ì´¼õ¥×ªÒƸøVLDL¡¢LDL£¬Æä½á¹ûÊÇHDL-CϽµ¡¢VLDL-C¡¢LDL-CÉÏÉý¡£

×îÔçµÄCETPÒÖÖÆ¼ÁÊÇ»ÔÈðµÄtorcetrapib (CP-529414)£¬2006ÄêÒòΪexcessive all-cause mortalityÐû¸æIIIÆÚÁÙ´²Ê§°Ü£¬ËðʧµÄÑз¢·ÑÓÃÔÚ8ÒÚÃÀÔªÒÔÉÏ¡£ÁíÒ»¸ö²»ºÃµÄÏûÏ¢À´×ÔRoche£¬dalcetrapib (JTT-705)Ò²ÓÚ2012ÄêÐû¸æIIIÆÚÁÙ´²Ê§°Ü£¬ÀíÓÉÊÇȱ·¦meaningful efficacy¡£

ÔÚÑеÄÁ½¸öCETPÒÖÖÆ¼ÁÊÇEli LillyµÄevacetrapib (LY2484595)ºÍMerckµÄanacetrapib (MK-0859)£¬Ä¿Ç°Eli LillyµÄpipelineÖÐÕÒ²»µ½evacetrapib£¬¿ÉÄÜÒѾ­·ÅÆúIIIÆÚÁÙ´²ÊÔÑé¡£MerckµÄanacetrapibÕýÔÚ×öIIIÆÚÁÙ´²ÊÔÑ飬µ«Õâ¼Ò¹«Ë¾½ü10ÄêµÄ±íÏÖÔ¶²»Èçǰ£¬È¥ÄêµÄ½µÖ¬Ò©Tredaptive£¨ÑÌËá+laropiprant£©¾ÍÔÚIIIÆÚÁÙ´²Ê§°Ü£¬ÈÃÈËÐÄÓÐÓà¼Â¡£

PCSK9È«³Æproprotein convertase subtilisin/kexin type 9£¬2003Äê·¢ÏÖPCSK9µ°°×£¬2006Äê·¢ÏÖPCSK9ÓëLDL-CµÄÁªÏµ£¬Ëæºó³ÉΪ½µÑªÖ¬µÄÈÈÃŰе㡣PCSK9ͨ¹ýÓëLDLRµÄEGF-A½á¹¹Óò½áºÏ£¬ÓÕµ¼LDLR½µ½â£¬´Ó¶øÏµ÷LDL´úл£¬Ôì³ÉLDL»ý¾Û¶øÒýÆð¸ßѪ֬¡£

˵ÆðPCSK9¾Í²»µÃ²»ÌáRegeneron Pharma£¬Õâ¼ÒÉúÎï¼¼Êõ¹«Ë¾ÒÔ¿ÆÑÐÎÅÃûÓÚÊÀ£¬Ä¿Ç°Òѳɹ¦ÉÏÊÐEylea£¨°¢°ØÎ÷ÆÕ£¬ÓÃÓÚÖÎÁÆÊªÐÔAMD£©¡¢Arcalyst£¨ÁÐÂåÎ÷ÆÕ£¬ÓÃÓÚÖÎÁÆCryopyrinµ°°×Ïà¹Ø×ÛºÏÕ÷£©¡¢Zaltrap£¨ziv-°¢°ØÎ÷ÆÕ£¬ÓÃÓÚÖÎÁƽáÖ±³¦°©£©£¬±»ÓþΪÏÂÒ»¸öAmgen¡£

Alirocumab (REGN727/SAR236553)ÊÇRegeneronµÄÓÖÒ»Æ·ÅÆÔÚÑÐÒ©ÎÓëSanofiºÏ×÷½øÐÐIIIÆÚÁÙ´²ÊÔÑ飬Ŀǰ¸ÃÒ©µÄÊÐֵΪ21ÒÚÃÀÔª¡£×ßÔÚRegeneronÖ®ºóµÄÊÇAmgenµÄAMG145£¬Ä¿Ç°´¦ÓÚIIIÆÚÁÙ´²£¬Ò²ÊÇAmgenµÄÊ×ÒªÔÚÑÐÒ©Îï¡£MerckÒ²²»¸Ê¼Åį×öÁ˸ö1D05-IgG2 (J Lipid Res. 2011, 52, 78-86.)£¬Éд¦ÓÚÔçÆÚÑз¢½×¶Î¡£

[ Last edited by ³ÕÃÎäìÏæ on 2013-8-24 at 03:18 ]
»Ø¸´´ËÂ¥

» ÊÕ¼±¾ÌûµÄÌÔÌûר¼­ÍƼö

»¯Ñ§Ò©ÎïºÏ³É·Ïß¿ª·¢Ó빤ÒÕ

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

mollyzhang

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ÊÇEli LillyµÄevacetrapib ÒѾ­½øÈëÈýÆÚÁÙ´²ÁË£¬Ó¦¸Ãû·ÅÆú
5Â¥2013-08-24 17:39:12
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 9 ¸ö»Ø´ð

fengfeng18602

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

ÎçÒ¹½ÖÍ·µÄÀËÈË

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Â¥Ö÷ÐÁ¿àÁË£¬Ñ§Ï°ÁË£¡
ëüëÊÓë»ìã磬¾ÍÊÇÎÒµÄ
2Â¥2013-08-24 08:54:42
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

yanghuping

ľ³æ (ÕýʽдÊÖ)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ÔçÆÚÐÅÏ¢¸Ã´ÓÄÄÀï»ñµÃ°¡£¡£¡£¡£¡
3Â¥2013-08-24 09:49:21
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

lingqin2013

ľ³æ (СÓÐÃûÆø)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Â¥Ö÷ÐÁ¿àÁË£¬Ð´µÃºÜºÃ£¬
·þÎñÒ©ÎﴴУ¬Ô츣ÈËÀàÉç»á¡£
4Â¥2013-08-24 13:40:27
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Ò»Ö¾Ô¸085802 323·ÖÇóµ÷¼Á +11 drizzle_9 2026-04-12 12/600 2026-04-12 22:07 by fqwang
[¿¼ÑÐ] ÉúÎïѧ308Çóµ÷¼Á +5 ÏàÐűػá¹ââÍòÕ 2026-04-11 5/250 2026-04-12 18:14 by zhouxiaoyu
[¿¼ÑÐ] Ò»Ö¾Ô¸»ªÖÐũ΢ÉúÎ288·Ö£¬ÈýÄêʵÑé¾­Àú +11 ´úfish 2026-04-09 11/550 2026-04-12 10:21 by Hayaay
[¿¼ÑÐ] µ÷¼Á +10 ÔÂ@163.com 2026-04-11 10/500 2026-04-12 09:14 by zhouyuwinner
[¿¼ÑÐ] 312Çóµ÷¼Á +6 Àîºè·É·É 2026-04-06 6/300 2026-04-12 00:34 by À¶ÔÆË¼Óê
[¿¼ÑÐ] »¯Ñ§308·ÖÇóµ÷¼Á +22 ÄãºÃÃ÷ÌìÄãºÃ 2026-04-07 24/1200 2026-04-11 11:14 by ChemPharm
[¿¼ÑÐ] 300·ÖÇóµ÷¼Á £¨085501»úеר˶£¬±¾¿ÆÑï´ó£© +8 xu@841019 2026-04-11 8/400 2026-04-11 10:46 by qingpingzhu
[¿¼ÑÐ] 085404 293Çóµ÷¼Á +9 ÓÂÔ¶¿â°®314 2026-04-06 10/500 2026-04-11 10:36 by ×ÏêØ×ÏÆå
[¿¼ÑÐ] »¹Óл¯¹¤¶þÂÖµ÷¼ÁµÄѧУÂð 5+14 »¯¹¤ÈË999 2026-04-09 48/2400 2026-04-11 10:27 by 89436494
[¿¼ÑÐ] 22408 327·ÖÇóµ÷¼Á +4 ÔÏ·çkon 2026-04-10 4/200 2026-04-11 09:51 by Öí»á·É
[¿¼ÑÐ] 311Çóµ÷¼Á +13 xypÏë¶ÁÊé 2026-04-10 14/700 2026-04-11 09:41 by Öí»á·É
[¿¼ÑÐ] ±¾9 Ò»Ö¾Ô¸Î÷¹¤´ó085601 324Çóµ÷¼Á +5 wysyjs25 2026-04-10 5/250 2026-04-10 16:57 by luoyongfeng
[¿¼ÑÐ] 071000ÉúÎïѧµ÷¼ÁÇóÖú +17 zzzzwww 2026-04-09 20/1000 2026-04-10 15:55 by Çóµ÷¼Ázz
[¿¼ÑÐ] 314Çóµ÷¼Á +14 weltZeng 2026-04-09 14/700 2026-04-09 23:14 by wolf97
[¿¼ÑÐ] 0703»¯Ñ§Çóµ÷¼Á +21 ²»ÖªÃûµÄСئ 2026-04-08 21/1050 2026-04-09 18:55 by l_paradox
[¿¼ÑÐ] 348Çóµ÷¼Á +3 candyyyi 2026-04-09 3/150 2026-04-09 17:20 by ¶ÎΰÑÞ
[¿¼ÑÐ] ¿¼Ñе÷¼Á +13 ±ù±ù£¬£¬£¬ 2026-04-07 13/650 2026-04-09 17:01 by Lilly_Li
[¿¼ÑÐ] Èí¼þ¹¤³ÌÇóµ÷¼Á22Èí¹¤296·ÖÇóµ÷¼Á£¬½ÓÊÜ¿çµ÷ +4 yangchen2017 2026-04-08 5/250 2026-04-08 21:56 by ÍÁľ˶ʿÕÐÉú
[¿¼ÑÐ] 344Çóµ÷¼Á +11 κ×Óper 2026-04-07 11/550 2026-04-07 23:01 by JourneyLucky
[¿¼ÑÐ] 259Çóµ÷¼Á +5 ¾Í°®³ÔÍÁ¶¹Ñ½Ñ½ 2026-04-07 5/250 2026-04-07 22:40 by JourneyLucky
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û